Drug Profile
Research programme: small molecule therapeutics - VasGene Therapeutics
Alternative Names: VAS 012Latest Information Update: 22 Jan 2016
Price :
$50
*
At a glance
- Originator VasGene Therapeutics
- Class Small molecules
- Mechanism of Action Rho-associated kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Jan 2016 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 30 Nov 2010 Preclinical trials in Cancer in USA (unspecified route)